Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis

Trial Profile

Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis

Completed
Phase of Trial: Phase I/II

Latest Information Update: 10 Oct 2016

At a glance

  • Drugs Triamcinolone (Primary)
  • Indications Uveitis
  • Focus Adverse reactions
  • Sponsors Clearside Biomedical
  • Most Recent Events

    • 10 Oct 2016 According to a Clearside Biomedical media release, results from the study will be presented at the Retina Sub-Specialty Day Meeting at the 2016 American Academy of Ophthalmology (AAO) Meeting.
    • 03 Aug 2016 According to a Clearside Biomedical media release, combined results from this and a phase II study (Profile 700249389) will be presented at the 2016 Annual Meeting of the American Society of Retina Specialists (ASRS).
    • 16 Mar 2015 According to Clearside Biomedical media release, status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top